Molecule.one is a chemistry artificial intelligence company that develops autonomous discovery software for chemical research. Headquartered in Portola Valley, California, the company operates research and technical facilities to accelerate laboratory workflows.
Subscribe to see Molecule.one’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Molecule.one is a biotechnology company headquartered in Poland. It has raised at least $5.6M across the 2 funding rounds on record. Its most recent funding round, Pre-seed, raised $1M in July 2026. Xcout tracks 5 named people at Molecule.one, including Dr. Piotr Byrski (CEO and Co-Founder).
At least $5.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $1M | 8 named | |
| Seed | $4.6M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Molecule.one's closest competitors — see the full list of competitors and alternatives →
Aether Bio is a biotechnology company headquartered in Menlo Park, California, that develops AI-designed molecular machines. Utilizing its Protein Function Model, the company accelerates protein discovery for advanced manufacturing, super materials, and critical mineral processing.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.